Geode Capital Management
XGN icon

Geode Capital Management’s Exagen XGN Stock Holding History

Geode Capital Management’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.52M Buy
186,642
+988
+0.5% +$6.35K ﹤0.01% 3231
2026
Q2 		$864K Buy
185,654
+6,797
+4% +$25.6K ﹤0.01% 3410
2026
Q1 		$537K Buy
178,857
+6,185
+4% +$23.9K ﹤0.01% 3560
2025
Q4 		$1.05M Buy
172,672
+9,417
+6% +$85.7K ﹤0.01% 3364
2025
Q3 		$1.79M Buy
163,255
+16,772
+11% +$149K ﹤0.01% 3213
2025
Q2 		$1.02M Buy
146,483
+45,884
+46% +$279K ﹤0.01% 3316
2025
Q1 		$361K Buy
100,599
+2,542
+3% +$9.6K ﹤0.01% 3659
2024
Q4 		$402K Buy
98,057
+10,442
+12% +$37.6K ﹤0.01% 3679
2024
Q3 		$271K Hold
87,615
– – ﹤0.01% 3800
2024
Q2 		$160K Buy
87,615
+6,032
+7% +$10.2K ﹤0.01% 3993
2024
Q1 		$130K Hold
81,583
– – ﹤0.01% 4076
2023
Q4 		$162K Hold
81,583
– – ﹤0.01% 4009
2023
Q3 		$200K Buy
81,583
+6,583
+9% +$16.7K ﹤0.01% 3980
2023
Q2 		$218K Hold
75,000
– – ﹤0.01% 4010
2023
Q1 		$182K Hold
75,000
– – ﹤0.01% 4098
2022
Q4 		$180K Sell
75,000
-167
-0.2% -$428 ﹤0.01% 4154
2022
Q3 		$203K Hold
75,167
– – ﹤0.01% 4206
2022
Q2 		$431K Sell
75,167
-78,333
-51% -$456K ﹤0.01% 3845
2022
Q1 		$1.23M Buy
153,500
+2,676
+2% +$23.1K ﹤0.01% 3517
2021
Q4 		$1.75M Sell
150,824
-9,370
-6% -$110K ﹤0.01% 3429
2021
Q3 		$2.18M Buy
160,194
+21,444
+15% +$285K ﹤0.01% 3309
2021
Q2 		$2.08M Buy
138,750
+55,799
+67% +$856K ﹤0.01% 3259
2021
Q1 		$1.45M Buy
82,951
+4,799
+6% +$85.5K ﹤0.01% 3408
2020
Q4 		$1.03M Buy
78,152
+1,107
+1% +$15.6K ﹤0.01% 3363
2020
Q3 		$835K Sell
77,045
-1,833
-2% -$23.6K ﹤0.01% 3270
2020
Q2 		$978K Buy
78,878
+13,377
+20% +$181K ﹤0.01% 3143
2020
Q1 		$1.04M Buy
65,501
+11,069
+20% +$220K ﹤0.01% 3006
2019
Q4 		$1.38M Buy
+54,432
New +$968K ﹤0.01% 3155

Other funds holding XGN

First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
RS
R Squared Central, Hong Kong $188M AUM 18.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $33.5B AUM 25.57% 1-Year Est. Return
Penbrook Management
Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return

Geode Capital Management's XGN Position: Q3 2026 in Review

Geode Capital Management increased its Exagen (XGN) stake by 0.53% in Q3 2026, buying an estimated $6.35K and bringing the position to 186,642 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #3231.

Geode Capital Management first reported a position in XGN in Q4 2019 and has held it in 28 quarters since. The position peaked at $2.18M in Q3 2021. 20 funds tracked by Wall St. Rank hold XGN as of Q3 2026.

  • Geode Capital Management held 186,642 shares of Exagen worth $1.52M as of Q3 2026.
  • Geode Capital Management bought 988 Exagen shares in Q3 2026, an estimated $6.35K.
  • Exagen made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3231 holding.
  • Geode Capital Management first reported a position in Exagen in Q4 2019 and has held it in 28 quarters since.
  • Geode Capital Management's Exagen position peaked at $2.18M in Q3 2021.
  • 20 funds tracked by Wall St. Rank held Exagen as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.